Optimal cut-off value of procalcitonin and procalcitonin/albumin ratio for predicting bacteremia among patients living with cancer: a test-negative case-control study

References

• Salomão R, Ferreira BL, Salomão MC, et al. Sepsis: evolving concepts and challenges. Braz J Med Biol Res. 2019;52(4):e8595. doi:10.1590/1414-431X20198595.
   PubMed Web of Science ®Google Scholar
• Póvoa P, Coelho L, Dal-Pizzol F, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med. 2023;49(2):142–153. doi:10.1007/s00134-022-06956-y.
   PubMed Web of Science ®Google Scholar
• Müller B, White JC, Nylén ES, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86(1):396–404. doi:10.1210/jc.86.1.396.
   PubMed Web of Science ®Google Scholar
• Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518. doi:10.1016/0140-6736(93)90277-n.
   PubMed Web of Science ®Google Scholar
• Wacker C, Prkno A, Brunkhorst FM, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–435. doi:10.1016/S1473-3099(12)70323-7.
   PubMed Web of Science ®Google Scholar
• Rodríguez AH, Avilés-Jurado FX, Díaz E, et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis. J Infect. 2016;72(2):143–151. doi:10.1016/j.jinf.2015.11.007.
   PubMed Web of Science ®Google Scholar
• Jong E, Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819–827. doi:10.1016/S1473-3099(16)00053-0.
   PubMed Web of Science ®Google Scholar
• Li T, Li X, Liu X, et al. Association of procalcitonin to albumin ratio with the presence and severity of sepsis in neonates. J Inflamm Res. 2022;15:2313–2321. PMID: 35437348; PMCID: PMC9013250. doi:10.2147/JIR.S358067.
   PubMed Web of Science ®Google Scholar
• Kochanek M, Schalk E, von Bergwelt-Baildon M, et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the ınfectious diseases working party (AGIHO) and ıntensive care working party (iCHOP) of the german society of hematology and medical oncology (DGHO). Ann Hematol. 2019;98(5):1051–1069. Epub 2019 Feb 22. PMID: 30796468; PMCID: PMC6469653. doi:10.1007/s00277-019-03622-0.
   PubMed Web of Science ®Google Scholar
• Moore JX, Akinyemiju T, Bartolucci A, et al. A prospective study of cancer survivors and risk of sepsis within the REGARDS cohort. Cancer Epidemiol. 2018;55:30–38. doi:10.1016/j.canep.2018.05.001.
   PubMed Web of Science ®Google Scholar
• Boucher JE, Carpenter D. Sepsis: symptoms, assessment, diagnosis, and the hour-1 bundle in patients With cancer. Clin J Oncol Nurs. 2020;24(1):99–102. doi:10.1188/20.CJON.99-102.
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. Epub 2011 Jul 27. PMID: 21793988. doi:10.1111/j.1469-0691.2011.03570.x.
   PubMed Web of Science ®Google Scholar
• Conlon C. Sepsis in ımmunocompromised hosts. J R Coll Physicians Lond. 2000;34(6):533–536.
   PubMedGoogle Scholar
• Amanati A, Sajedianfard S, Khajeh S, et al. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect Dis. 2021;21(1):636. Published 2021 Jul 2. doi:10.1186/s12879-021-06243-z.
   PubMed Web of Science ®Google Scholar
• Silva M, Oliveira-Figueiredo S, Cavalcanti D. Prevalence and factors associated with sepsis and septic shock in oncological patients in intensive therapy. Rev Bras Enferm. 2021;75(1):e20201338. doi:10.1590/0034-7167-2020-1338.
   PubMed Web of Science ®Google Scholar
• Lakbar I, Einav S, Lalevée N, et al. Interactions between gender and sepsis—ımplications for the future. Microorganisms. 2023;11(3):746. doi:10.3390/microorganisms11030746.
   PubMed Web of Science ®Google Scholar
• Rowe TA, McKoy JM. Sepsis in older adults. Infect Dis Clin North Am. 2017;31(4):731–742. doi:10.1016/j.idc.2017.07.010.
   PubMed Web of Science ®Google Scholar
• Te Marvelde L, Whitfield A, Shepheard J, et al. Epidemiology of sepsis in cancer patients in Victoria, Australia: a population-based study using linked data. Aust N Z J Public Health. 2020;44(1):53–58. doi:10.1111/1753-6405.12935.
   PubMed Web of Science ®Google Scholar
• Bou Chebl R, Safa R, Sabra M, et al. Sepsis in patients with haematological versus solid cancer: a retrospective cohort study. BMJ Open. 2021;11(2):e038349. doi:10.1136/bmjopen-2020-038349.
   PubMed Web of Science ®Google Scholar
• Torres VBL, Azevedo LCP, Silva UVA, et al. Sepsis-Associated outcomes in critically ıll patients with malignancies. Ann Am Thorac Soc. 2015;12(8):1185–1192. doi:10.1513/AnnalsATS.201501-046OC.
   PubMed Web of Science ®Google Scholar
• Lemiale V, Pons S, Mirouse A, et al. Sepsis and septic shock in patients With malignancies: a groupe de recherche respiratoire en réanimation Onco-Hématologique study*. Crit Care Med. 2020;48(6):822–829. doi:10.1097/CCM.0000000000004322.
   PubMed Web of Science ®Google Scholar
• Nazer L, Lopez-Olivo MA, Cuenca JA, et al. All-cause mortality in cancer patients treated for sepsis in intensive care units: a systematic review and meta-analysis. Support Care Cancer. 2022;30(12):10099–10109. doi:10.1007/s00520-022-07392-w.
   PubMed Web of Science ®Google Scholar
• Pizzo PA, Ladisch S, Simon RM, et al. Increasing incidence of gram-positive sepsis in cancer patients. Med Pediatr Oncol. 1978;5(1):241–244. doi:10.1002/mpo.2950050133.
   PubMedGoogle Scholar
• Chinowaita F, Chaka W, Nyazika TK, et al. Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns. BMC Infect Dis. 2020;20(1):161. Published 2020 Feb 21. doi:10.1186/s12879-020-4886-2.
   PubMed Web of Science ®Google Scholar
• Ștreangă V, Stângă OM, Nistor N, et al. Biomarkeri de diagnostic în sepsis. Pediatru ro. 2020;1(57):14. doi:10.26416/Pedi.57.1.2020.3066.
   Google Scholar
• Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217. Epub 2004 Jul 2. Erratum in: clin Infect Dis. 2005 May 1;40(9):1386–8. PMID: 15307030. doi:10.1086/421997.
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Kuittinen T, Matinlauri I, et al. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma. 2008;49(3):495–501. PMID: 18297526. doi:10.1080/10428190701809172.
   PubMed Web of Science ®Google Scholar
• Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the sepsis-3 definitions. BMC Infect Dis. 2019;19(1):968. PMID: 31718563; PMCID: PMC6852730. doi:10.1186/s12879-019-4618-7.
   PubMed Web of Science ®Google Scholar
• Piperidou A, Zografos E, Vassilakopoulos TJ, et al. Serum procalcitonin levels in newly diagnosed hodgkin lymphoma: correlation with other ınflammatory biomarkers. Medicina (Kaunas). 2022;58(10):1331. PMID: 36295492; PMCID: PMC9609271. doi:10.3390/medicina58101331.
   PubMed Web of Science ®Google Scholar
• Mustafić S, Brkić S, Prnjavorac B, et al. Diagnostic and prognostic value of procalcitonin in patients with sepsis. Med Glas (Zenica). 2018;15(2):93–100. PMID: 30047536. doi:10.17392/963-18.
   PubMedGoogle Scholar
• Jones AE, Fiechtl JF, Brown MD, et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50(1):34–41. doi:10.1016/j.annemergmed.2006.10.020.
   PubMed Web of Science ®Google Scholar
• Wu SC, Liang CX, Zhang YL, et al. Elevated serum procalcitonin level in patients with chronic kidney disease without infection: a case-control study. J Clin Lab Anal. 2020;34(2):e23065. Epub 2019 Oct 16. PMID: 31617251; PMCID: PMC7031592. doi:10.1002/jcla.23065.
   PubMed Web of Science ®Google Scholar
• Luo X, Yang X, Li J, et al. The procalcitonin/albumin ratio as an early diagnostic predictor in discriminating urosepsis from patients with febrile urinary tract infection. Medicine (Baltimore). 2018;97(28):e11078. PMID: 29995751; PMCID: PMC6076169. doi:10.1097/MD.0000000000011078.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Pearce N. Test-Negative designs: differences and commonalities with other case-control studies with "other patient" controls. Epidemiology. 2019;30(6):838–844. PMID: 31430265. doi:10.1097/EDE.0000000000001088.
   PubMed Web of Science ®Google Scholar